The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMinoan Regulatory News (MIN)

Share Price Information for Minoan (MIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.675
Bid: 0.65
Ask: 0.70
Change: -0.075 (-10.00%)
Spread: 0.05 (7.692%)
Open: 0.75
High: 0.75
Low: 0.675
Prev. Close: 0.75
MIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results Announcement

31 Jul 2023 07:00

RNS Number : 6409H
Minoan Group PLC
31 July 2023
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 31 July 2023

Interim Results Announcement

Minoan Group Plc

(the "Group" or the "Company" or "Minoan")

 

Minoan Group Plc, the AIM listed resort development company presents its unaudited interim results for the six months ended 30 April 2023.

 

 

KEY POINTS

 

· Discussions with the Public Welfare Ecclesiastical Foundation Panagia Akrotiriani ("the Foundation") in relation to the Master contract continue and remain in line with the published timeline.

· The detailed environmental study for the Masterplan which follows the Presidential Decree is making good progress.

· Commercial discussions and other negotiations relating to the Project continue with further NDAs expected in the coming period.

· The Loss for the period was almost halved compared to the same period last year to £286,000 (2021/22: £542,000).

 

 

Christopher Egleton, Chairman of Minoan, said:

 

"In April of this year, the Company laid out the key milestones and timeline that it expects for the conclusion of the Project. The Company continues to follow this and George Mergos and I very much look forward to updating Shareholders with progress in the near future."

 

The Company's unaudited interim results for the six months ended 30 April 2023 can be viewed on Minoan's website, www.minoangroup.com, with effect from 31 July 2023.

 

 

For further information visit www.minoangroup.com or contact:

 

Minoan Group Plc

Christopher Egleton christopher.egleton@minoangroup.com

George Mergos georgios.mergos@minoangroup.com

W H Ireland Limited 020 7220 1666 Antonio Bossi

 

Peterhouse Capital Limited 020 7469 0930

Duncan Vasey

Chairman's Statement

 

 

Introduction

 

I am pleased to present the unaudited interim results for Minoan Group Plc for the six months to 30 April 2023.

During the period, Loyalward Limited, the Group's wholly owned subsidiary and owner of the Project, under the leadership of George Mergos, continued to make good progress with the Itanos Gaia Project in Crete (the "Project").

Discussions with the Public Welfare Ecclesiastical Foundation Panagia Akrotiriani (the "Foundation") are proceeding well with a number of meetings having taken place in the period and subsequently. These discussions are on a practical basis and the Company remains confident that they can be concluded in the coming months.

Alongside these discussions, work is being undertaken on the detailed environmental study for the Masterplan which follows the requirements arising from the Presidential Decree. I look forward to be able to announce the conclusion of this in due course.

As I reported in April, the discussions with the Foundation are not impeding progress on the Project itself, as we are moving forward based on the existing contractual documentation. This has enabled the management team to proceed with certainty and to undertake the Commercial and other negotiations relating to the Project. The Board expects further Non Disclosure Agreements to be signed in the coming period.

 

 

Financial Review

 

The Board is pleased to note the reduction in the loss for the six months period to 30 April 2023. The loss before taxation was £286,000 compared to £542,000 in the same period last year. The Company continues to focus on the key activities necessary to drive the Project forward.

 

Total assets at 30 April 2023 totalled £51,475,000 (2021: £50,907,000).

 

 

Outlook

 

In April of this year, the Company laid out the key milestones and timeline that it expects for the conclusion of the Project. The Company continues to follow this and George Mergos and I very much look forward to updating Shareholders with progress in the near future.

 

 

 

 

Christopher W Egleton

Chairman

31 July 2023

 

Unaudited Consolidated Statement of Comprehensive Income

Six months ended 30 April 2023

 

6 months ended 30.04.23

£'000

6 months ended 30.04.22

£'000

 Year ended 31.10.22

 £'000

 

 

Revenue

-

-

-

 

Cost of sales

 

-

 

-

 

-

 

Gross profit

 

-

 

-

 

-

 

Operating expenses

(220)

(264)

(541)

 

Operating loss

(220)

(264)

(541)

 

Finance costs

(66)

(278)

(524)

 

Loss before taxation

 

(286)

 

(542)

 

(1,065)

 

 

Taxation

-

-

-

 

Loss for period attributable to equity holders of the Company

(286)

(542)

 

 

(1,065)

 

Loss per share attributable to equity holders of the Company: Basic and diluted

 

 

(0.04)p

 

 

 (0.09)p

 

 

(0.16)p

 

 

 

 

 

Unaudited Consolidated Statement of Changes in Equity

Six months ended 30 April 2023

 

 

 

 

Share capital

£'000

Share premium

£'000

Merger

reserve £'000

Warrant reserve

£000

Retained earnings £'000

Total

equity £'000

 

 

 

 

 

 

 

Balance at 1 November 2022

20,321

36,583

9,349

2,619

(26,183)

42,689

Loss for the period

-

-

-

-

(286)

 (286)

Issue of ordinary shares

27

-

-

-

 -

27

Share based payments

-

-

-

-

-

-

Balance at 30 April 2023

20,348

36,583

9,349

2,619

(26,469)

42,430

 

 

 

 

Six months ended 30 April 2022

 

Share capital

£'000

Share premium

£'000

Merger

reserve £'000

Warrant reserve

£000

Retained earnings £'000

Total

equity £'000

Balance at 1 November 2021

19,021

36,583

9,349

2,571

(25,118)

 42,406

Loss for the period

-

-

-

-

(542)

 (542)

Issue of ordinary shares

150

-

-

-

 -

150

Share based payments

-

-

-

47

-

47

Balance at 30 April 2022

19,171

36,583

9,349

2,618

(25,660)

42,061

 

 

 

 

Year ended 31 October 2022

 

Share capital

£'000

Share premium

£'000

Merger

reserve £'000

Warrant reserve

£000

Retained earnings £'000

Total

equity £'000

Balance at 1 November 2021

19,021

36,583

9,349

2,571

(25,118)

42,406

Loss for the year

-

-

-

-

(1,065)

 (1,065)

Issue of ordinary shares

1,300

-

-

-

 -

1,300

Share based payments

-

-

-

48

-

48

Balance at 31 October 2022

20,321

36,583

9,349

2,619

(26,183)

42,689

 

 

 

 

 

Unaudited Consolidated Statement of Financial Position as at 30 April 2023

 

 

As at 30.04.23£'000

 

As at 30.04.22£'000

As at 31.10.22£'000

Assets

 

Non-current assets

 

Intangible assets

3,583

3,583

3,583

Property, plant and equipment

157

157

157

Total non-current assets

3,740

3,740

3,740

 

 

Current assets

 

Inventories

47,561

47,004

47,388

Receivables

159

158

167

Cash and cash equivalents

15

5

130

Total current assets

47,735

47,167

47,685

 

Total assets

51,475

50,907

51,425

 

 

Equity

 

Share capital

20,348

19,171

20,321

Share premium account

36,583

36,583

36,583

Merger reserve account

9,349

9,349

9,349

Warrant reserve

2,619

2,618

2,619

Retained earnings

(26,469)

(25,660)

(26,183)

Total equity

42,430

42,061

42,689

 

 

Liabilities

 

Current liabilities

9,045

8,846

8,736

 

 

Total equity and liabilities

51,475

50,907

51,425

 

 

 

Unaudited Consolidated Cash Flow Statement

Six months ended 30 April 2023

 

 

6 months ended 30.04.23

£'000

6 months ended 30.04.22

£'000

Year ended 31.10.22

£'000

 

 

Loss before taxation

 (286)

(542)

(1,065)

Finance costs

66

278

524

Increase in inventories

(173)

(246)

(630)

Decrease in receivables

8

4

5

Increase in current liabilities

234

418

370

Net cash (outflow) from operations

(151)

(88)

(806)

Finance costs

(66)

(231)

(476)

Net cash used in operating activities

(217)

(319)

(1,282)

 

Cash flows from investing activities

 

Purchase of property, plant and equipment

-

-

-

Purchase of intangible assets

-

-

-

Net cash used in investing activities

-

-

-

 

 

Cash flows from financing activities

 

Net proceeds from the issue of ordinary shares

27

150

1,300

Net loans received / (repaid)

75

154

92

 

102

304

1,392

 

 

Net (decrease) / increase in cash

(115)

(15)

110

 

 

Cash at beginning of period

130

20

20

Cash at end of period

15

5

130

 

 

 

 

Notes to the Unaudited Financial Statements

Six months ended 30 April 2023

 

 

1. General information

 

The Company is a public limited company incorporated in England and Wales. The Company's principal activity in the period under review was that of a holding and management company of a Group involved in the design, creation, development and management of environmentally friendly luxury hotels and resorts plus the provision of general management services.

 

2. Basis of preparation

 

The interim financial statements are unaudited and do not constitute statutory accounts as defined in Section 434(3) of the Companies Act 2006. A copy of the audited Report and Financial Statements for the year ended 31 October 2021 has been delivered to the Registrar of Companies. The auditor's report on these accounts was unqualified and did not contain statements under s498(2) to s498(4) of the Companies Act 2006.

 

These interim financial statements for the six months ended 30 April 2023 comprise an Unaudited Consolidated Statement of Profit and Loss and Other Comprehensive Income, Unaudited Consolidated Statement of Changes in Equity, Unaudited Consolidated Statement of Financial Position and Unaudited Consolidated Cash Flow Statement plus relevant notes.

 

The interim financial statements are prepared in accordance with EU adopted International Financial Reporting Standards ("IFRS") and the International Financial Reporting Interpretations Committee ("IFRIC") interpretations and the Companies Act 2006 applicable to companies reporting under IFRS.

 

The principal accounting policies adopted in the preparation of the interim financial statements are consistent with those adopted in the Report and Financial Statements for the year ended 31 October 2022.

 

Going concern

 

The directors have considered the financial and commercial position of the Group in relation to its Project in Crete (the "Project"). In particular, the directors have reviewed the matters referred to below.

 

Following the unanimous approval of a Plenum of the Greek Council of State, the highest court in Greece, the Presidential Decree granting land use approval for the Project was issued on 11 March 2016 and was published in the Government Gazette. The planning rules for the Project are now enshrined in law. The appeals lodged against the Presidential Decree have been rejected by the Greek Supreme Court. Accordingly, the directors consider that they will conclude further Project joint venture agreements in the near term.

 

In addition to specific Project related matters as noted above, and as has been the case in the past, the Group continues to need to raise capital in order to meet its existing finance and working capital requirements. While the directors consider that any necessary funds will be raised as required, the ability of the Company to raise these funds is, by its nature, uncertain.

 

Having taken these matters into account, the directors consider that the going concern basis of preparation of the financial statements is appropriate.

 

Notes to the Unaudited Financial Statements (continued)

Six months ended 30 April 2023

 

3. Loss per share attributable to equity holders of the Company

 

Earnings per share are calculated by dividing the earnings attributable to the equity holders of a company by the weighted average number of ordinary shares in issue during the period. Diluted earnings per share are

calculated by adjusting basic earnings per share to assume the conversion of all dilutive potential ordinary shares. There are no dilutive instruments in issue, therefore the basic loss per share and diluted loss per share are the same. The weighted average number of shares used in calculating basic and diluted loss per share for the six months ended 30 April 2023 was 733,131,124. (Six months ended 30 April 2022: 612,627,502; Year ended 31 October 2022: 647,900,567).

 

4. Share based payments charge

 

In accordance with IAS 32, the Share based payments charge in respect of warrants finance charges has been included in Finance costs in the Unaudited Consolidated Statement of Comprehensive Income.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FLFVDDFIIVIV
Date   Source Headline
30th Apr 202411:55 amRNSResult of Annual General Meeting
30th Apr 20247:00 amRNSUpdate
29th Apr 20244:40 pmRNSIssue of Shares
8th Apr 20247:00 amRNSNotice of Annual General Meeting
8th Mar 20247:00 amRNSChange of Director
5th Jan 20247:00 amRNSOption Expiry Extension and Shareholder Update
14th Nov 20237:00 amRNSIssue of Shares
10th Nov 202311:46 amRNSResults of AGM and GM
10th Nov 20237:00 amRNSShareholder Update
18th Oct 20237:00 amRNSNotices for the Re-convened AGM & General Meeting
29th Sep 20237:00 amRNSTiming of Forthcoming Meetings
29th Aug 20237:00 amRNSLoan Repayment & Extension and Share Issuance
1st Aug 20237:05 amRNSIssue of Shares
1st Aug 20237:00 amRNSInitial Agreement with Hotel Operator
31st Jul 20237:00 amRNSInterim Results Announcement
5th Jun 20237:00 amRNSMinoan Group Publishes Research Note
28th Apr 202310:58 amRNSResult of Annual General Meeting
28th Apr 20237:04 amRNSAnnual Results for the Year Ended 31 October 2022
6th Apr 20237:00 amRNSNotice of Annual General Meeting
21st Mar 20239:47 amRNSExercise of Options
5th Jan 20237:00 amRNSUpdate and Option Expiry Dates
9th Dec 20227:00 amRNSAppointment of Savills as an Advisor
24th Oct 20222:15 pmRNSPlacing and Directors’ Shareholdings
13th Oct 20227:00 amRNSAppointment to the Board of Loyalward Limited
29th Jul 20221:55 pmRNSInterim Results Announcement
26th Jul 20227:00 amRNSSignificant Shareholding
20th Jul 20227:00 amRNSShare Issue
18th Jul 20227:00 amRNSLoan Extension
29th Jun 20222:09 pmRNSCompany Update
6th Jun 20223:35 pmRNSResult of Re-convened Annual General Meeting
12th May 20227:00 amRNSNotice of Re-convened Annual General Meeting
3rd May 20224:49 pmRNSPlacing and Director / PDMR Shareholding
29th Apr 202210:32 amRNSResult of Annual General Meeting
28th Apr 20227:00 amRNSPreliminary Results for the Year Ended 31 Oct 2021
7th Apr 20227:00 amRNSNotice of Annual General Meeting
25th Mar 202211:25 amRNSGeorge Mergos Appointed Chair of Loyalward Limited
15th Feb 20227:00 amRNSCompany Update
30th Dec 20217:00 amRNSShare Issue and Option Expiry Dates
9th Dec 20217:00 amRNSUpdate on new Law on Strategic Investments
1st Dec 202112:45 pmRNSNew Development Law and Loan Extension
29th Oct 202111:27 amRNSLoan Extension
30th Jul 20217:00 amRNSResults of Placing
29th Jul 20217:00 amRNSInterim Results for the period ended 30 April 2021
28th May 202110:43 amRNSResult of Re-convened AGM
6th May 20217:00 amRNSNotice of Re-convened Annual General Meeting
30th Apr 202110:25 amRNSResult of AGM
30th Apr 20217:00 amRNSPreliminary Results for the year ended 31 Oct 2020
14th Apr 202112:54 pmRNSHolding(s) in Company
14th Apr 202112:48 pmRNSSignificant Shareholding
8th Apr 20217:00 amRNSNotice of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.